Oct. 9 at 4:43 PM
$RNAC we should be getting the data for SLE (LUPUS) phase 2 trial any day now, and if the data is good, the stock price should move up quite dramatically. This could be the turning point this ticker has needed to get Wall Street on board with their technology.